From Congress to Clinic: A Post-ESMO Breast Cancer 2021 Update on Immune-Based Therapies in Triple-Negative Breast Cancer

Download All
Get up to speed on immune-based therapies for triple-negative breast cancer including the most clinically relevant data from ESMO Breast Cancer 2021 with this on-demand webcast and downloadable slides from a live CCO webinar.
person default
Nadia Harbeck, MD, PhD
Ian E. Krop, MD, PhD

On-Demand Webcast

Learn from the experts about the latest evidence on immune-based therapies in triple-negative breast cancer including checkpoint inhibitors and novel antibody-drug conjugates.

person default Nadia Harbeck, MD, PhD Ian E. Krop, MD, PhD Physicians: maximum of 1.0 AMA PRA Category 1 Credit Released: June 2, 2021 Expired: June 1, 2022

Slidesets

Download these slides from a live webinar to gain expert insight on the latest evidence and rationale for immunotherapy in TNBC

person default Nadia Harbeck, MD, PhD Released: May 11, 2021

Download these slides from a live webinar to gain expert insight into the latest evidence on antibody-drug conjugates and their evolving role in TNBC

Ian E. Krop, MD, PhD Released: May 11, 2021
Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by an educational grant from
Daiichi Sankyo, Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue